Axogen to Participate in the 77th Annual Meeting of the American Society for Surgery of the Hand
22 September 2022 - 9:00PM
Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and
marketing innovative surgical solutions for damage or discontinuity
to peripheral nerves, announced that it will participate in the
77th Annual Meeting of the American Society for Surgery of the Hand
(ASSH) being held in Boston from September 29-October 1, 2022.
During the conference Axogen will host an industry forum
symposium entitled Late-Breaking, State-of-the-Art Nerve
Reconstruction Data: The How and Why of Implementing this New Data
into Your Clinical Practice on Friday, September 30, 7:00-8:00 a.m.
ET. This session will feature interactive Q&A with surgeon
investigators who will present the results of a newly completed
randomized controlled trial in nerve repair, as well as a new
comprehensive peripheral nerve repair meta-analysis comparing
outcomes for autograft and allograft in both sensory and
mixed/motor nerve repairs.
Surgeons in attendance will have the opportunity to meet and
participate in hands-on demonstrations with Axogen staff,
clinicians, and other experts at Booth #815 in the Solutions Center
(exhibit hall). Fully equipped microscope stations will engage
surgeons to learn more about microsurgical techniques, product
handling, and other innovative surgical solutions for peripheral
nerve repair. In addition to interactive opportunities at the
booth, surgeons will be invited to meet top Axogen scientists at an
Innovation Lab to dive deeper into how science is improving nerve
repair.
In addition to the symposium, Axogen will support the Young
Surgeons Skills Bootcamp, the Women in Hand Surgery, and will
sponsor two travel scholarships for residents or Fellows to attend
the meeting in Boston.
“We look forward to meeting and connecting with hand surgeons
during our symposium and at our booth,” said Karen Zaderej,
chairman, CEO, and president of Axogen. “The annual ASSH conference
is a valuable event for driving innovation, and an important forum
for Axogen’s expanding portfolio of clinical data, as we continue
to pursue our mission of improving the quality of life for patients
with peripheral nerve damage.”
Axogen is proud to support various research, education, and
outreach programs of the ASSH throughout the year, including the
ASSH Touching Hands International Missions. These missions provide
life-changing hand surgeries, rehabilitation, and medical training
in the world’s most underserved communities.
About ASSHThe American Society for Surgery of
the Hand is the oldest medical society dedicated to the hand and
upper extremity. Its mission is to advance the science and practice
of hand and upper extremity surgery through education, research,
and advocacy on behalf of patients and practitioners. For more
information, please visit www.assh.org.
About AxogenAxogen (AXGN) is the
leading company focused specifically on the science, development,
and commercialization of technologies for peripheral nerve
regeneration and repair. Axogen employees are passionate about
helping to restore peripheral nerve function and quality of life to
patients with physical damage or transection to peripheral nerves
by providing innovative, clinically proven, and economically
effective repair solutions for surgeons and health care providers.
Peripheral nerves provide the pathways for both motor and sensory
signals throughout the body. Every day, people suffer traumatic
injuries or undergo surgical procedures that impact the function of
their peripheral nerves. Physical damage to a peripheral
nerve, or the inability to properly reconnect peripheral nerves,
can result in the loss of muscle or organ function, the loss of
sensory feeling, or the initiation of pain.
Axogen's platform for peripheral nerve repair
features a comprehensive portfolio of products, including Avance®
Nerve Graft, a biologically active off-the-shelf processed human
nerve allograft for bridging severed peripheral nerves without the
comorbidities associated with a second surgical site; Axoguard
Nerve Connector®, a porcine submucosa extracellular matrix (ECM)
coaptation aid for tensionless repair of severed peripheral nerves;
Axoguard Nerve Protector®, a porcine submucosa ECM product used to
wrap and protect damaged peripheral nerves and reinforce the nerve
reconstruction while preventing soft tissue attachments; and
Axoguard Nerve Cap®, a porcine submucosa ECM product used to
protect a peripheral nerve end and separate the nerve from the
surrounding environment to reduce the development of symptomatic or
painful neuroma. The Axogen portfolio of products is available in
the United States, Canada, Germany, the United Kingdom, Spain,
South Korea, and several other countries.
Contact:Axogen, Inc.Ed Joyce, Director, Investor
Relationsejoyce@axogeninc.com
Axogen (NASDAQ:AXGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Axogen (NASDAQ:AXGN)
Historical Stock Chart
From Apr 2023 to Apr 2024